USE OF 1-THIA-DIBENZO E,H AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
申请人:GlaxoSmithKline istrazivacki centar Zagreb d.o.o.
公开号:EP1684751B1
公开(公告)日:2007-09-12
US7262302B2
申请人:——
公开号:US7262302B2
公开(公告)日:2007-08-28
1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
申请人:Mercep Mladen
公开号:US20060111340A1
公开(公告)日:2006-05-25
The present invention relates to derivatives of 1-thia-3-aza-dibenzoazulene class, to their pharmacologically acceptable salts and solvates, to processes and intermediates for the preparation thereof as well as to their antiinflammatory effects, especially to the inhibition of tumour necrosis factor-α (TNF-α) production and the inhibition of interleukin-1 (IL-1) production as well as to their analgetic action.